Literature DB >> 28724544

MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.

Amanda R Campbell1,2, Megan C Duggan1,2, Lorena P Suarez-Kelly1, Neela Bhave1, Kallan S Opheim1, Elizabeth L McMichael1,2, Prashant Trikha1, Robin Parihar1, Eric Luedke1,3, Adrian Lewis1, Bryant Yung4, Robert Lee4, David Raulet5, Susheela Tridandapani6, Veronika Groh7, Lianbo Yu8, Vedat Yildiz8, John C Byrd1,9, Michael A Caligiuri1,9, William E Carson10,3.   

Abstract

Natural killer (NK) cells are large granular lymphocytes that promote the antitumor response via communication with other cell types in the tumor microenvironment. Previously, we have shown that NK cells secrete a profile of immune stimulatory factors (e.g., IFNγ, MIP-1α, and TNFα) in response to dual stimulation with the combination of antibody (Ab)-coated tumor cells and cytokines, such as IL12. We now demonstrate that this response is enhanced in the presence of autologous monocytes. Monocyte enhancement of NK cell activity was dependent on cell-to-cell contact as determined by a Transwell assay. It was hypothesized that NK cell effector functions against Ab-coated tumor cells were enhanced via binding of MICA on monocytes to NK cell NKG2D receptors. Strategies to block MICA-NKG2D interactions resulted in reductions in IFNγ production. Depletion of monocytes in vivo resulted in decreased IFNγ production by murine NK cells upon exposure to Ab-coated tumor cells. In mice receiving trastuzumab and IL12 therapy, monocyte depletion resulted in significantly greater tumor growth in comparison to mock-depleted controls (P < 0.05). These data suggest that NK cell-monocyte interactions enhance NK cell antitumor activity in the setting of monoclonal Ab therapy for cancer. Cancer Immunol Res; 5(9); 778-89. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28724544      PMCID: PMC5581690          DOI: 10.1158/2326-6066.CIR-16-0005

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  47 in total

1.  Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes.

Authors:  Y Amakata; Y Fujiyama; A Andoh; K Hodohara; T Bamba
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 2.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

3.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

4.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.

Authors:  Courtney A Crane; Kathryn Austgen; Kristen Haberthur; Carly Hofmann; Kara White Moyes; Lia Avanesyan; Lawrence Fong; Michael J Campbell; Stewart Cooper; Scott A Oakes; Andrew T Parsa; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

6.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Authors:  Mercedes Kloss; Patrice Decker; Katrin M Baltz; Tina Baessler; Gundram Jung; Hans-Georg Rammensee; Alexander Steinle; Matthias Krusch; Helmut R Salih
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection.

Authors:  Brian Badgwell; Robin Parihar; Cynthia Magro; Julie Dierksheide; Thomas Russo; William Edgar Carson
Journal:  Surgery       Date:  2002-08       Impact factor: 3.982

9.  Cutting edge: tumor-targeting antibodies enhance NKG2D-mediated NK cell cytotoxicity by stabilizing NK cell-tumor cell interactions.

Authors:  Jacques Deguine; Béatrice Breart; Fabrice Lemaître; Philippe Bousso
Journal:  J Immunol       Date:  2012-11-26       Impact factor: 5.422

10.  Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.

Authors:  Biljana Zafirova; Sanja Mandarić; Ronald Antulov; Astrid Krmpotić; Helena Jonsson; Wayne M Yokoyama; Stipan Jonjić; Bojan Polić
Journal:  Immunity       Date:  2009-07-23       Impact factor: 31.745

View more
  12 in total

1.  Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.

Authors:  Prakash Babu Narasimhan; Tobias Eggert; Yanfang Peipei Zhu; Paola Marcovecchio; Melissa A Meyer; Runpei Wu; Catherine C Hedrick
Journal:  J Immunol       Date:  2019-11-25       Impact factor: 5.422

2.  CD8+ T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy.

Authors:  Jillian Rosenberg; Jun Huang
Journal:  Curr Opin Chem Eng       Date:  2017-12-14       Impact factor: 5.163

3.  Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression.

Authors:  Neekun Sharma; Mary A Markiewicz
Journal:  Blood Adv       Date:  2019-05-28

Review 4.  Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses.

Authors:  Alexandre Morrot; Leonardo Marques da Fonseca; Eduardo J Salustiano; Luciana Boffoni Gentile; Luciana Conde; Alessandra Almeida Filardy; Tatiany Nunes Franklim; Kelli Monteiro da Costa; Celio Geraldo Freire-de-Lima; Leonardo Freire-de-Lima
Journal:  Front Oncol       Date:  2018-03-23       Impact factor: 6.244

Review 5.  Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.

Authors:  Martina Di Modica; Elda Tagliabue; Tiziana Triulzi
Journal:  Dis Markers       Date:  2017-12-18       Impact factor: 3.434

Review 6.  The Paradoxical Role of NKG2D in Cancer Immunity.

Authors:  Sam Sheppard; Amir Ferry; Joana Guedes; Nadia Guerra
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

7.  Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.

Authors:  Brooke Benner; Luke Scarberry; Lorena P Suarez-Kelly; Megan C Duggan; Amanda R Campbell; Emily Smith; Gabriella Lapurga; Kallie Jiang; Jonathan P Butchar; Susheela Tridandapani; John Harrison Howard; Robert A Baiocchi; Thomas A Mace; William E Carson
Journal:  J Immunother Cancer       Date:  2019-05-28       Impact factor: 13.751

Review 8.  More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Authors:  Andrew P Trembath; Mary A Markiewicz
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

Review 9.  The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

10.  Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.

Authors:  Carlos R Figueiredo; Helen Kalirai; Joseph J Sacco; Ricardo A Azevedo; Andrew Duckworth; Joseph R Slupsky; Judy M Coulson; Sarah E Coupland
Journal:  J Pathol       Date:  2020-04       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.